April 3, 2018 / 7:39 AM / 4 months ago

BRIEF-Orion Updates Primary Completion Date Of Phase III To September 2018

April 3 (Reuters) - Orion Oyj:

* STATUS UPDATE OF THE PHASE III ARAMIS CLINICAL TRIAL WITH DAROLUTAMIDE IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

* ESTIMATED PRIMARY COMPLETION DATE IS NOW UPDATED TO SEPTEMBER 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below